London’s Albion Capital has announced its intention to raise £80 million with provisions for an additional £20 million in aggregate across its six funds. In total, these funds account for approximately £545 million in AUM. Focusing primarily on UK-based B2B software, healthcare, and tech-enabled services startups, Albion Capital typically invests between £2 million to £5 million in Series A and early Series B rounds.
Building upon the success of 2021’s £58.5 million raise, Albion Capital is eyeballing a strong pipeline of investment opportunities ahead, and in addition to providing support for approximately 70 existing portfolio companies, wants to bring more fledgling businesses into the flock.
Across the six Albion VCTs (Albion Development, Albion Enterprise, Albion Technology & General, Albion Venture Capital Trust, Crown Place, and Kings Arms Yard), these portfolio companies employ approximately 3,500 people, with the top 15 investments posting positive revenue growth of 35%, resulting in a combined total of over £120 million over the last twelve months. A small sampling of the firms’ investments includes financial crime fighter Quantexa, children’s medicine developer Proveca, and diet and lifestyle coaching app Oviva.
“This new fundraise demonstrates Albion Capital’s ongoing commitment to supporting the UK’s most ambitious, innovative companies which are at an inflection point in their development, requiring additional funding to accelerate growth,” explains Albion Capital managing partner Will Fraser-Allen. “Despite the incredible progress and acceleration of digital adoption in recent years there is no slowing of investment opportunities and we remain extremely optimistic about the future.”